Nuclear Imaging Devices And Equipment Global Market Opportunities And Strategies To 2031

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	354 Pages	The Business Research Company	January, 2023	BRC17695544

Best Price Guarantee
Price	from $5,000
Length	354 Pages
Publisher	The Business Research Company
Published Date	January, 2023
SKU	BRC17695544

Nuclear Imaging Devices And Equipment Global Market Opportunities And Strategies To 2031

Nuclear Imaging Devices And Equipment Global Market Opportunities And Strategies To 2031 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global nuclear imaging devices and equipment market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest-growing market for nuclear imaging devices and equipment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The nuclear imaging devices and equipment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider nuclear imaging devices and equipment market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics: Brief introduction to the segmentations covered in the market, definitions and explanations about nuclear imaging devices and equipment market.
Key Trends: Highlights the major trends shaping the global nuclear imaging devices and equipment market. This section also highlights likely future developments in the market.
Global Market Size and Growth: Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis: Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.
Market Segmentation: Contains the market values (2016-2031) and analysis for for segment by end user, by application, and by end user in the market.
Regional Market Size and Growth: Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape: Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Key Mergers and Acquisitions: Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies: This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations: This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for nuclear imaging devices and equipment providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
Appendix: This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Product Type: SPECT Systems; PET Systems; Planar Scintigraphy Systems

2) By Application: Oncology; Cardiology; Neurology; Other Applications

3) By End-User: Hospitals; Imaging Centers; Academic & Research Institutes; Other End-Users

Companies Mentioned: Siemens Healthineers AG; Koninklijke Philips N.V.; Canon Inc; General Electric Company; Cardinal Health, Inc

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; nuclear imaging devices and equipment market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction and Market Characteristics: 6.1. General Market Definition; 6.2. Summary; 6.3. Multiplex Assays Market Definition and Segmentations; 6.4. Market Segmentation By Type; 6.4.1. Protein-Based Multiplex Assays; 6.4.2. Nucleic Acid-Based Multiplex Assays; 6.4.3. Other Types; 6.5. Market Segmentation By Identification Technology; 6.5.1. Flow Cytometry; 6.5.2. Multiplex Real-Time PCR; 6.5.3. Other Identification Technologies; 6.6. Market Segmentation By Detection Technology; 6.6.1. Enzyme-Linked Immunosorbent Assay (ELISA); 6.6.2. Luminescence; 6.6.3. Fluorescence; 6.6.4. Other Detection Technologies; 6.7. Market Segmentation By Application; 6.7.1. Research And Development; 6.7.2. Clinical Diagnostics; 6.8. Market Segmentation By End-User; 6.8.1. Pharmaceutical And Biotechnology Companies; 6.8.2. Hospitals And Research Institutes; 6.8.3. Reference Laboratories; 6.8.4. Other End-Users
7. Major Market Trends: 7.1. Automated Molecular Diagnostics Platforms; 7.2. Launch Of Innovative Tests; 7.3. Development Of New COVID-19 Test Kits; 7.4. Launch Of New Assays With Enhanced Software; 7.5. New Product Launches; 7.6. Strategic Partnerships And Collaborations
8. Global Market Size And Growth: 8.1. Market Size; 8.2. Historic Market Growth, 2016 – 2021, Value ($ Million); 8.2.1. Market Drivers 2016 – 2021; 8.2.2. Market Restraints 2016 – 2021; 8.3. Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 8.3.1. Market Drivers 2021 – 2026; 8.3.2. Market Restraints 2021 – 2026
9. Global Market Segmentation: 9.1. Global Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 9.2. Global Multiplex Assays Market, Segmentation By Identification Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 9.3. Global Multiplex Assays Market, Segmentation By Detection Technology, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 9.4. Global Multiplex Assays Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 9.5. Global Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 9.5.1. Global Clinical Diagnostics Market, By Disease, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
10. Global Market, Regional And Country Analysis: 10.1. Global Multiplex Assays Market, By Region, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 10.2. Global Multiplex Assays Market, By Country, Historic and Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
11. Asia-Pacific Market: 11.1. Summary; 11.2. Market Overview; 11.2.1. Region Information; 11.2.2. Market Information; 11.2.3. Background Information; 11.2.4. Government Initiatives; 11.2.5. Regulations; 11.2.6. Regulatory Bodies; 11.2.7. Major Associations; 11.2.8. Taxes Levied; 11.2.9. Corporate Tax Structure; 11.2.10. Investments; 11.2.11. Major Companies; 11.3. Asia-Pacific Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.4. Asia-Pacific Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.5. Asia-Pacific Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.6. Asia-Pacific Multiplex Assays Market, Segmentation By End-User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.7. Asia-Pacific Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.8. Asia Pacific Multiplex Assays Market: Country Analysis; 11.9. China Market; 11.10. Summary; 11.11. Market Overview; 11.11.1. Country Information; 11.11.2. Market Information; 11.11.3. Background Information; 11.11.4. Government Initiatives; 11.11.5. Regulations; 11.11.6. Regulatory Bodies; 11.11.7. Major Associations; 11.11.8. Taxes Levied; 11.11.9. Corporate Tax Structure; 11.11.10. Investments; 11.11.11. Major Companies; 11.12. China Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.13. China Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.14. China Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.15. China Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.16. China Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.17. India Market; 11.18. India Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.19. India Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.20. India Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.21. India Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.22. India Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.23. Japan Market; 11.24. Japan Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.25. Japan Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.26. Japan Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.27. Japan Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.28. Japan Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.29. Australia Market; 11.30. Australia Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.31. Australia Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.32. Australia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.33. Australia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.34. Australia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.35. Indonesia Market; 11.36. Indonesia Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.37. Indonesia Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.38. Indonesia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.39. Indonesia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.40. Indonesia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.41. South Korea Market; 11.42. South Korea Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 11.43. South Korea Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 11.44. South Korea Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.45. South Korea Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 11.46. South Korea Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
12. Western Europe Market: 12.1. Summary; 12.2. Market Overview; 12.2.1. Region Information; 12.2.2. Market Information; 12.2.3. Background Information; 12.2.4. Government Initiatives; 12.2.5. Regulations; 12.2.6. Regulatory Bodies; 12.2.7. Major Associations; 12.2.8. Taxes Levied; 12.2.9. Corporate Tax Structure; 12.2.10. Investments; 12.2.11. Major Companies; 12.3. Western Europe Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 12.4. Western Europe Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 12.5. Western Europe Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.6. Western Europe Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.7. Western Europe Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.8. Western Europe Multiplex Assays Market: Country Analysis; 12.9. UK Market; 12.10. UK Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 12.11. UK Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 12.12. UK Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.13. UK Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.14. UK Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.15. Germany Market; 12.16. Germany Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 12.17. Germany Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 12.18. Germany Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.19. Germany Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.20. Germany Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.21. France Market; 12.22. France Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 12.23. France Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 12.24. France Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.25. France Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 12.26. France Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
13. Eastern Europe Market: 13.1. Summary; 13.2. Market Overview; 13.2.1. Region Information; 13.2.2. Market Information; 13.2.3. Background Information; 13.2.4. Government Initiatives; 13.2.5. Regulations; 13.2.6. Regulatory Bodies; 13.2.7. Major Associations; 13.2.8. Taxes Levied; 13.2.9. Corporate Tax Structure; 13.2.10. Investments; 13.2.11. Major Companies; 13.3. Eastern Europe Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.4. Eastern Europe Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.5. Eastern Europe Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.6. Eastern Europe Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.7. Eastern Europe Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.8. Eastern Europe Multiplex Assays Market: Country Analysis; 13.9. Russia Market; 13.10. Russia Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 13.11. Russia Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 13.12. Russia Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.13. Russia Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 13.14. Russia Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
14. North America Market: 14.1. Summary; 14.2. Market Overview; 14.2.1. Region Information; 14.2.2. Market Information; 14.2.3. Background Information; 14.2.4. Government Initiatives; 14.2.5. Regulations; 14.2.6. Regulatory Bodies; 14.2.7. Major Associations; 14.2.8. Taxes levied; 14.2.9. Corporate Tax Structure; 14.2.10. Investments; 14.2.11. Major Companies; 14.3. North America Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.4. North America Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.5. North America Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.6. North America Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.7. North America Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.8. North America Multiplex Assays Market: Country Analysis; 14.9. USA Market; 14.10. Summary; 14.11. Market Overview; 14.11.1. Country Information; 14.11.2. Market Information; 14.11.3. Background Information; 14.11.4. Government Initiatives; 14.11.5. Regulations; 14.11.6. Regulatory Bodies; 14.11.7. Major Associations; 14.11.8. Taxes Levied; 14.11.9. Corporate Tax Structure; 14.11.10. Investments; 14.11.11. Major Companies; 14.12. USA Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 14.13. USA Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 14.14. USA Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.15. USA Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 14.16. USA Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
15. South America Market: 15.1. Summary; 15.2. Market Overview; 15.2.1. Region Information; 15.2.2. Market Information; 15.2.3. Background Information; 15.2.4. Government Initiatives; 15.2.5. Regulations; 15.2.6. Regulatory Bodies; 15.2.7. Major Associations; 15.2.8. Taxes Levied; 15.2.9. Corporate Tax Structure; 15.2.10. Investments; 15.2.11. Major Companies; 15.3. South America Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 15.4. South America Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 15.5. South America Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.6. South America Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.7. South America Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.8. South America Multiplex Assays Market: Country Analysis; 15.9. Brazil Market; 15.10. Brazil Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 15.11. Brazil Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 15.12. Brazil Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.13. Brazil Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 15.14. Brazil Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
16. Middle East Market: 16.1. Summary; 16.2. Market Overview; 16.2.1. Region Information; 16.2.2. Market Information; 16.2.3. Background Information; 16.2.4. Government Initiatives; 16.2.5. Regulations; 16.2.6. Regulatory Bodies; 16.2.7. Major Associations; 16.2.8. Taxes Levied; 16.2.9. Corporate Tax Structure; 16.2.10. Investments; 16.2.11. Major Companies; 16.3. Middle East Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 16.4. Middle East Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 16.5. Middle East Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 16.6. Middle East Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 16.7. Middle East Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
17. Africa Market: 17.1. Summary; 17.2. Market Overview; 17.2.1. Region Information; 17.2.2. Market Information; 17.2.3. Background Information; 17.2.4. Government Initiatives; 17.2.5. Regulations; 17.2.6. Regulatory Bodies; 17.2.7. Major Associations; 17.2.8. Taxes Levied; 17.2.9. Corporate Tax Structure; 17.2.10. Investments; 17.2.11. Major Companies; 17.3. Africa Multiplex Assays Market, Historic Market Growth, 2016 – 2021, Value ($ Million); 17.4. Africa Multiplex Assays Market, Forecast Market Growth, 2021 – 2026, 2031F Value ($ Million); 17.5. Africa Multiplex Assays Market, Segmentation By Type, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 17.6. Africa Multiplex Assays Market, Segmentation By End User, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million); 17.7. Africa Multiplex Assays Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, Value ($ Million)
18. Competitive Landscape and Company Profiles
19. Company Profiles: 19.1. Seegene Inc; 19.1.1. Company Overview; 19.1.2. Products And Services; 19.1.3. Business Strategy; 19.1.4. Financial Overview; 19.2. DiaSorin SpA; 19.2.1. Company Overview; 19.2.2. Products And Services; 19.2.3. Business Strategy; 19.2.4. Financial Overview; 19.3. Thermo Fisher Scientific Inc; 19.3.1. Company Overview; 19.3.2. Products And Services; 19.3.3. Business Strategy; 19.3.4. Financial Overview; 19.4. Bio-Rad Laboratories Inc; 19.4.1. Company Overview; 19.4.2. Products And Services; 19.4.3. Business Strategy; 19.4.4. Financial Overview; 19.5. Qiagen NV; 19.5.1. Company Overview; 19.5.2. Products And Services; 19.5.3. Business Strategy; 19.5.4. Financial Overview
20. Key Mergers And Acquisitions: 20.1. CellCarta Acquired Commercial Rights To The Antibody Panels And Assays From Precision Assays; 20.2. Univercells Technologies Acquired SynHelix; 20.3. Roche Acquired TIB Molbiol; 20.4. Becton, Dickinson And Company Acquired Scanwell Health; 20.5. Mylab Discovery Solutions Partnered With Hemex Health; 20.6. Illumina Acquired GRAIL; 20.7. XPhyto Therapeutics Acquired 3a Diagnostics; 20.8. Roche Acquired GenMark; 20.9. Danaher Acquired Swift Biosciences; 20.10. Thermo Fisher Scientific Acquired Mesa Biotech; 20.11. Merck Acquired AmpTec; 20.12. Abcam Acquired Expedeon; 20.13. Tulip Diagnostics Acquired Biosense Technologies; 20.14. Edan Diagnostics, Inc. Acquired Molecular Diagnostics; 20.15. Siemens Healthineers AG Acquired Minicare BV
21. Opportunities And Strategies: 21.1. Global Multiplex Assays Market In 2026 – Countries Offering Most New Opportunities; 21.2. Global Multiplex Assays Market In 2026 – Segments Offering Most New Opportunities; 21.3. Global Multiplex Assays Market In 2026 – Growth Strategies; 21.3.1. Market Trend Based Strategies; 21.3.2. Competitor Strategies
22. Multiplex Assays Market, Conclusions And Recommendations: 22.1. Conclusions; 22.2. Recommendations; 22.2.1. Product; 22.2.2. Place; 22.2.3. Price; 22.2.4. Promotion; 22.2.5. People
23. Appendix: 23.1. Market Data Sources; 23.2. Research Methodology; 23.3. Currencies; 23.4. The Business Research Company; 23.5. Copyright and Disclaimer